Logo image of MRM

MEDIROM HEALTHCARE TECHNOLOG (MRM) Stock Fundamental Analysis

NASDAQ:MRM - Nasdaq - US58510H1032 - ADR - Currency: USD

1.78  +0.48 (+36.92%)

After market: 1.8 +0.02 (+1.12%)

Fundamental Rating

1

Overall MRM gets a fundamental rating of 1 out of 10. We evaluated MRM against 73 industry peers in the Diversified Consumer Services industry. Both the profitability and financial health of MRM have multiple concerns. MRM is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

MRM had positive earnings in the past year.
In the past year MRM has reported a negative cash flow from operations.
The reported net income has been mixed in the past 5 years: MRM reported negative net income in multiple years.
MRM had negative operating cash flow in 4 of the past 5 years.
MRM Yearly Net Income VS EBIT VS OCF VS FCFMRM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 0 -500M -1B -1.5B

1.2 Ratios

MRM has a Return On Assets of 1.68%. This is comparable to the rest of the industry: MRM outperforms 58.90% of its industry peers.
MRM has a better Return On Equity (54.73%) than 94.52% of its industry peers.
Industry RankSector Rank
ROA 1.68%
ROE 54.73%
ROIC N/A
ROA(3y)-4.44%
ROA(5y)-4.48%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MRM Yearly ROA, ROE, ROICMRM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 0 200 -200 400

1.3 Margins

MRM has a better Profit Margin (1.69%) than 60.27% of its industry peers.
MRM's Profit Margin has declined in the last couple of years.
MRM has a worse Gross Margin (22.98%) than 78.08% of its industry peers.
MRM's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM N/A
PM (TTM) 1.69%
GM 22.98%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5Y-2.63%
GM growth 3Y21.41%
GM growth 5Y-3.79%
MRM Yearly Profit, Operating, Gross MarginsMRM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 0 10 -10 20

More info and screens

0

2. Health

2.1 Basic Checks

MRM does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, MRM has about the same amount of shares outstanding.
The number of shares outstanding for MRM has been increased compared to 5 years ago.
The debt/assets ratio for MRM is higher compared to a year ago.
MRM Yearly Shares OutstandingMRM Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2M 4M 6M
MRM Yearly Total Debt VS Total AssetsMRM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2B 4B 6B

2.2 Solvency

Based on the Altman-Z score of 0.64, we must say that MRM is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of MRM (0.64) is comparable to the rest of the industry.
MRM has a Debt/Equity ratio of 6.88. This is a high value indicating a heavy dependency on external financing.
MRM has a worse Debt to Equity ratio (6.88) than 79.45% of its industry peers.
Industry RankSector Rank
Debt/Equity 6.88
Debt/FCF N/A
Altman-Z 0.64
ROIC/WACCN/A
WACC4.98%
MRM Yearly LT Debt VS Equity VS FCFMRM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 0 500M -500M 1B -1B -1.5B

2.3 Liquidity

MRM has a Current Ratio of 0.49. This is a bad value and indicates that MRM is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.49, MRM is not doing good in the industry: 78.08% of the companies in the same industry are doing better.
A Quick Ratio of 0.45 indicates that MRM may have some problems paying its short term obligations.
The Quick ratio of MRM (0.45) is worse than 78.08% of its industry peers.
Industry RankSector Rank
Current Ratio 0.49
Quick Ratio 0.45
MRM Yearly Current Assets VS Current LiabilitesMRM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 1B 2B 3B

More info and screens

2

3. Growth

3.1 Past

MRM shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -17.97%.
MRM shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 10.09% yearly.
MRM shows a decrease in Revenue. In the last year, the revenue decreased by -1.81%.
Measured over the past years, MRM shows a quite strong growth in Revenue. The Revenue has been growing by 14.74% on average per year.
EPS 1Y (TTM)-17.97%
EPS 3YN/A
EPS 5Y10.09%
EPS Q2Q%58.23%
Revenue 1Y (TTM)-1.81%
Revenue growth 3Y26.9%
Revenue growth 5Y14.74%
Sales Q2Q%-5.83%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MRM Yearly Revenue VS EstimatesMRM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2B 4B 6B

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 29.67, which means the current valuation is very expensive for MRM.
Based on the Price/Earnings ratio, MRM is valued a bit cheaper than the industry average as 67.12% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of MRM to the average of the S&P500 Index (26.03), we can say MRM is valued inline with the index average.
Industry RankSector Rank
PE 29.67
Fwd PE N/A
MRM Price Earnings VS Forward Price EarningsMRM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MRM Per share dataMRM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)2.94
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

MRM does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MEDIROM HEALTHCARE TECHNOLOG

NASDAQ:MRM (5/21/2025, 8:00:01 PM)

After market: 1.8 +0.02 (+1.12%)

1.78

+0.48 (+36.92%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)05-30 2023-05-30
Earnings (Next)N/A N/A
Inst Owners1.55%
Inst Owner Change47.18%
Ins Owners24.94%
Ins Owner ChangeN/A
Market Cap14.07M
Analysts0
Price TargetN/A
Short Float %2.59%
Short Ratio0.07
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 29.67
Fwd PE N/A
P/S 0.3
P/FCF N/A
P/OCF N/A
P/B 9.65
P/tB N/A
EV/EBITDA N/A
EPS(TTM)0.06
EY3.37%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-1.36
FCFYN/A
OCF(TTM)-0.55
OCFYN/A
SpS5.97
BVpS0.18
TBVpS-1.05
PEG (NY)N/A
PEG (5Y)2.94
Profitability
Industry RankSector Rank
ROA 1.68%
ROE 54.73%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 1.69%
GM 22.98%
FCFM N/A
ROA(3y)-4.44%
ROA(5y)-4.48%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5Y-2.63%
GM growth 3Y21.41%
GM growth 5Y-3.79%
F-Score2
Asset Turnover1
Health
Industry RankSector Rank
Debt/Equity 6.88
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 365.02%
Cap/Sales 13.5%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.49
Quick Ratio 0.45
Altman-Z 0.64
F-Score2
WACC4.98%
ROIC/WACCN/A
Cap/Depr(3y)181.87%
Cap/Depr(5y)124.18%
Cap/Sales(3y)6%
Cap/Sales(5y)3.85%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-17.97%
EPS 3YN/A
EPS 5Y10.09%
EPS Q2Q%58.23%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-1.81%
Revenue growth 3Y26.9%
Revenue growth 5Y14.74%
Sales Q2Q%-5.83%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-503.83%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-82.32%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y7.87%
OCF growth 3YN/A
OCF growth 5YN/A